Exposure and Response Prevention Therapy

BEHAVIORAL5 trials

Sponsors

Ruijin Hospital, New York State Psychiatric Institute, NOCD, Weill Medical College of Cornell University

Conditions

Obsessive-Compulsive Disorder

Phase 1

Cannabinoid Medication for Adults With OCD

CompletedNCT02911324

New York State Psychiatric InstituteObsessive-Compulsive Disorder

Start: 2016-09-30End: 2019-01-31Updated: 2020-08-06

Unknown Phase

Exposure and Response Prevention Therapy for Obsessive-compulsive Disorder

Ruijin HospitalObsessive-Compulsive Disorder

Start: 2016-11-30End: 2017-12-31Target: 48Updated: 2016-11-29

Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

CompletedNCT04701372

NOCDObsessive-Compulsive Disorder

Start: 2020-01-01End: 2020-11-08Updated: 2021-01-08

Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment

CompletedNCT06466447

NOCDObsessive-Compulsive Disorder

Start: 2020-07-23End: 2024-05-03Updated: 2024-06-26

Precision Brain Mapping to Predict and Track Response to Exposure and Response Prevention Therapy in Youth With Obsessive-Compulsive Disorder

WithdrawnNCT07570108

Weill Medical College of Cornell UniversityObsessive-Compulsive Disorder

Start: 2026-11-01End: 2031-11-01Updated: 2026-08-05